Hepion Pharmaceuticals provides unaudited balance sheet as of Jan 31, 2025; cash of $5.36M

Hepion Pharmaceuticals, Inc.

Cash and cash equivalents of $5.36M as of January 31, 2025.
Total assets of $6.5M, total liabilities of $0.55M.
Stockholders' equity of $5.95M, accumulated deficit of $238M.
No revenue or operational update provided; balance sheet only.

item 8.01 item 9.01

Hepion Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-009075

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.